Fluconazole Dosing with GFR 34.5 mL/min
For a patient with GFR 34.5 mL/min, administer a standard loading dose (typically 400-800 mg depending on indication), then reduce the maintenance dose by 50% of the usual daily dose. This means if the standard maintenance dose is 400 mg daily, give 200 mg daily; if 200 mg daily is standard, give 100 mg daily 111.
Rationale for Dose Adjustment
Fluconazole is primarily eliminated renally, with approximately 80% excreted unchanged in urine 12. The pharmacokinetics are markedly affected by renal impairment, with an inverse relationship between elimination half-life and creatinine clearance 11.
Your patient's GFR of 34.5 mL/min places them in the moderate renal impairment category (CKD Stage 3b: GFR 30-44 mL/min). Research demonstrates that in patients with creatinine clearance between 21-50 mL/min (mean 38 mL/min), the half-life extends to 84.5 hours compared to 36.7 hours in those with normal renal function 3. This prolonged half-life necessitates dose reduction to prevent drug accumulation and potential toxicity.
Specific Dosing Algorithm
Loading Dose (Day 1):
- Give the full standard loading dose based on the indication (e.g., 800 mg for candidemia, 400 mg for other invasive candidiasis) 44
- The loading dose does not require adjustment because initial AUC is proportional to dose and independent of renal function 3
Maintenance Dose (Day 2 onwards):
- Reduce to 50% of the standard maintenance dose 1
- Examples:
- Standard 400 mg daily → Give 200 mg daily
- Standard 200 mg daily → Give 100 mg daily
- Standard 100 mg daily → Give 50 mg daily
Clinical Context from Guidelines:
The IDSA guidelines recommend fluconazole 400 mg (6 mg/kg) daily for most invasive candidiasis after initial echinocandin therapy 44. For your patient with GFR 34.5, this translates to:
- Loading dose: 400 mg on Day 1
- Maintenance: 200 mg daily starting Day 2
Important Caveats
Hemodialysis consideration: If your patient progresses to requiring hemodialysis, note that a 3-hour session removes approximately 50% of plasma fluconazole 11. In hemodialysis patients, give 100-200 mg after each dialysis session 3.
Monitor for drug accumulation: The extended half-life (approaching 85-100 hours in moderate-to-severe renal impairment) means steady-state takes longer to achieve 3. Consider therapeutic drug monitoring if available, particularly for serious infections.
Recent pharmacokinetic modeling suggests eGFR-based dosing with a loading dose of 2.8 times the maintenance dose may optimize outcomes 5, though this approach requires prospective validation. The FDA-approved 50% dose reduction remains the standard of care for your patient's level of renal function.
Drug interactions: Fluconazole has minimal protein binding (11-12%) 1, reducing concerns about displacement interactions, but be vigilant for CYP450-mediated interactions with other medications your patient may be receiving.